title: Drug discovery targeted at transthyretin cardiac amyloidosis: rational design, synthesis, and biological activity of new transthyretin amyloid inhibitors.
authors.affiliation: Drug Discovery Platform, Parc Cientific Barcelona, Barcelona, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Blasi
authors.forename: M
authors.initials: M
authors.lastname: Pinto
authors.forename: J
authors.initials: J
authors.lastname: Nieto
authors.forename: G
authors.initials: G
authors.lastname: Arsequell
authors.forename: G
authors.initials: G
authors.lastname: Valencia
authors.forename: A
authors.initials: A
authors.lastname: Planas
authors.forename: N B
authors.initials: NB
authors.lastname: Centeno
authors.forename: J
authors.initials: J
authors.lastname: Quintana
mesh_terms: D000682:Amyloid / Q000037:antagonists & inhibitors*; D000686:Amyloidosis / Q000188:drug therapy* / Q000378:metabolism; D055808:Drug Discovery; D006331:Heart Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D011228:Prealbumin / Q000037:antagonists & inhibitors*
chemical_list: D000682:Amyloid; D011228:Prealbumin